On Tuesday, Palisade Bio Inc (NASDAQ: PALI) was 20.08% up from the session before settling in for the closing price of $4.93. A 52-week range for PALI has been $3.82 – $36.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales drop of Healthcare Sector giant was -38.82%. When this article was written, the company’s average yearly earnings per share was at 46.67%. With a float of $0.84 million, this company’s outstanding shares have now reached $0.85 million.
Let’s determine the extent of company efficiency that accounts for 9 employees.
Palisade Bio Inc (PALI) Insider Activity
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Palisade Bio Inc stocks. The insider ownership of Palisade Bio Inc is 1.75%, while institutional ownership is 2.09%. The most recent insider transaction that took place on Feb 06 ’24, was worth 4,692. In this transaction CEO, CFO, Director of this company bought 10,000 shares at a rate of $0.47, taking the stock ownership to the 84,649 shares. Before that another transaction happened on Jan 31 ’24, when Company’s Director bought 10,000 for $0.60, making the entire transaction worth $6,050. This insider now owns 30,000 shares in total.
Palisade Bio Inc (PALI) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 46.67% per share during the next fiscal year.
Palisade Bio Inc (NASDAQ: PALI) Trading Performance Indicators
You can see what Palisade Bio Inc (PALI) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.11. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 20.13.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -28.25, a number that is poised to hit -3.75 in the next quarter and is forecasted to reach -17.25 in one year’s time.
Technical Analysis of Palisade Bio Inc (PALI)
Looking closely at Palisade Bio Inc (NASDAQ: PALI), its last 5-days average volume was 5.09 million, which is a jump from its year-to-date volume of 0.86 million. As of the previous 9 days, the stock’s Stochastic %D was 23.44%. Additionally, its Average True Range was 1.16.
During the past 100 days, Palisade Bio Inc’s (PALI) raw stochastic average was set at 11.33%, which indicates a significant decrease from 36.02% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 254.21% in the past 14 days, which was higher than the 161.00% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.76, while its 200-day Moving Average is $10.58. However, in the short run, Palisade Bio Inc’s stock first resistance to watch stands at $7.50. Second resistance stands at $9.09. The third major resistance level sits at $10.00. If the price goes on to break the first support level at $5.00, it is likely to go to the next support level at $4.09. Should the price break the second support level, the third support level stands at $2.50.
Palisade Bio Inc (NASDAQ: PALI) Key Stats
There are 852K outstanding shares of the company, which has a market capitalization of 5.03 million. As of now, sales total 250 K while income totals -12,300 K. Its latest quarter income was 0 K while its last quarter net income were -2,970 K.
